FDA — authorised 1 April 1999
- Application: NDA021041
- Marketing authorisation holder: PACIRA PHARMS INC
- Local brand name: DEPOCYT
- Indication: INJECTABLE, LIPOSOMAL — INJECTION
- Status: approved
🇺🇸 Depocyt in United States
FDA authorised Depocyt on 1 April 1999
Marketing authorisation
Other Other approved in United States
Frequently asked questions
Is Depocyt approved in United States?
Yes. FDA authorised it on 1 April 1999.
Who is the marketing authorisation holder for Depocyt in United States?
PACIRA PHARMS INC holds the US marketing authorisation.